Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
Quinolone-3-amidoalkanol: A New Class of Potent and Broad-Spectrum Antimicrobial Agent
Dube, Phelelisiwe S. ; Angula, Klaudia T. ; Legoabe, Lesetja J. , et al. ACS Omega,2023,8(19):17086-17102. DOI: 10.1021/acsomega.3c01406 PubMed ID: 37214682
More
Abstract: Herein, we describe 39 novel quinolone compounds bearing a hydrophilic amine chain and varied substituted benzyloxy units. These compounds demonstrate broad-spectrum activities against acid-fast bacterium, Gram-pos. and -neg. bacteria, fungi, and leishmania parasite. Compound 30 maintained antitubercular activity against moxifloxacin-, isoniazid-, and rifampicin-resistant Mycobacterium tuberculosis, while 37 exhibited low micromolar activities (<1 μg/mL) against World Health Organization (WHO) critical pathogens: Cryptococcus neoformans, Acinetobacter baumannii, and Pseudomonas aeruginosa. Compounds in this study are metabolically robust, demonstrating % remnant of >98% after 30 min in the presence of human, rat, and mouse liver microsomes. Several compounds thus reported here are promising leads for the treatment of diseases caused by infectious agents.
Purchased from AmBeed: 403-19-0 ; 636-93-1 ; 5847-59-6 ; 87-13-8 ; 1548-61-4 ; 99-53-6 ; 402-49-3 ; 619-08-9 ; 18880-00-7 ; 111-41-1 ; 619-10-3 ; 766-80-3 ; 140-75-0 ; 823-78-9 ; 622-95-7 ; 402-23-3 ; 141776-91-2 ...More
CAS No. : | 636-93-1 | MDL No. : | MFCD00015561 |
Formula : | C7H7NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KXKCTSZYNCDFFG-UHFFFAOYSA-N |
M.W : | 169.14 | Pubchem ID : | 69471 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P273-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335-H412 | Packing Group: | N/A |
GHS Pictogram: |
2-Methoxy-5-nitrophenol (CAS: 636-93-1) can be used in the preparation of Bosutinib (SKI-606) (CAS: 380843-75-4). Bosutinib, a small molecule that inhibits BCR-ABL and src tyrosine kinases, is utilized for treating chronic myelogenous leukemia.
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With palladium on activated charcoal; hydrogen In methanol at 20℃; for 24 h; | To a solution of commercially available 2-methoxy-5-nitro-phenol: 1-01 a (40 g, 236.5 mmol) in MeOH (300 mL) was added Pd/C (3 g) under Ar. The suspension was degassed under vacuum and purged with H2 several times. The reaction mixture was stirred under H2 (40 psi) at RT for 24h. Then, the mixture was filtered and the filtrate was concentrated to give intermediate I- 16a (25g, 76percent) as a yellow solid. ESI-MS (M+1 ): 140.1 calc. for C7H9NO2: 139.06. |
[ 380844-49-5 ]
7-(3-Chloropropoxy)-4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinoline-3-carbonitrile
[ 22483-40-5 ]
1-(2-Methoxyethoxy)-4-nitrobenzene
Similarity: 0.92
[ 22483-40-5 ]
1-(2-Methoxyethoxy)-4-nitrobenzene
Similarity: 0.92
[ 22483-40-5 ]
1-(2-Methoxyethoxy)-4-nitrobenzene
Similarity: 0.92